Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2012 Sep 12;26(5):388–390. doi: 10.3341/kjo.2012.26.5.388

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2012 The Korean Ophthalmological Society

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 1 — (A-D) The right eye of the patient. (A) Before intravitreal bevacizumab plus triamcinolone injection, fundus showed cystic change of the macula. (B) Fluorescein angiograms (FA) showed hyperfluorescence in the macula in the late frame. (C) Optical coherence tomography (OCT) showed cystoid macular edema (CME). (D) Six weeks after the injection, CME was unchanged in OCT. (E-H) The left eye of the patient. (E) Before intravitreal bevacizumab plus triamcinolone injection, fundus showed cystic change of the macula. (F) FA showed hyperfluorescence in the macula in the late frame. (G) OCT showed CME. (H) Six weeks after the injection, CME was unchanged in OCT.